8-K - ACTUATE THERAPEUTICS, INC. (0001652935) (Filer)
Published . Updated .
8-K - ACTUATE THERAPEUTICS filed an 8-K with the SEC on Oct 28 (a notice of a material company event).
Directly affected
- ACTU Actuate Therapeutics
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ACTU | +31.10% | +21.30% | base | -3.74% | -12.91% | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-28 AccNo: 0001683168-26-008143 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
Price since this story was published: Actuate Therapeutics (ACTU)
| Company | When | Move | Status |
|---|---|---|---|
| Actuate Therapeutics (ACTU) | that day | -3.74% | final price |
| Actuate Therapeutics (ACTU) | the next day | -12.91% | final price |
| Actuate Therapeutics (ACTU) | three days earlier | +21.30% | final price |
| Actuate Therapeutics (ACTU) | five days earlier | +31.10% | final price |
Who gains and who loses around Actuate Therapeutics (ACTU)
Companies carried with this story
- ACTU Actuate Therapeutics
For “8-K - ACTUATE THERAPEUTICS, INC. (0001652935) (Filer),” Actuate Therapeutics (ACTU) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ACTU
How “8-K - ACTUATE THERAPEUTICS, INC. (0001652935) (Filer)” reaches Actuate Therapeutics (ACTU)
The 28 Oct 2026 story “8-K - ACTUATE THERAPEUTICS, INC. (0001652935) (Filer)” names Actuate Therapeutics (ACTU) because of this story.
For Actuate Therapeutics (ACTU), the reason on file says SEC 8-K filing -> direct issuer disclosure -> ACTU
Dates in the story, and the Actuate Therapeutics (ACTU) price range
ACTU traded between 0.36 and 1.06 across 4 sessions. The latest close on file is 0.37.
How strong the case is around Actuate Therapeutics (ACTU)
14 out of 100
“8-K - ACTUATE THERAPEUTICS, INC. (0001652935) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.